Alverine for cirrhosis-related high liver vein pressure
Part of Digestive system clinical trials.
This trial tests a medicine called alverine to see if it can lower high blood pressure in the liver's veins (portal hypertension) caused by cirrhosis. It may help prevent complications like bleeding or fluid buildup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with cirrhosis (liver scarring).
- Your liver vein pressure is high (≥12 mmHg).
- You have not taken certain blood pressure medicines or alverine in the past 4 weeks.
- You have not had a liver transplant or a procedure called TIPS.
- You do not have liver cancer or other cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if alverine, a medicine for gut spasms, can help lower high blood pressure in the liver caused by cirrhosis. You may qualify if you have cirrhosis with high liver pressure and haven't used certain other blood-pressure medicines recently.
This trial is for people with liver cirrhosis who already take carvedilol for portal hypertension (high blood pressure in the liver's main vein). It tests whether adding alverine helps lower that pressure more effectively.
This trial studies alverine to lower portal hypertension, which is high blood pressure in the liver that can happen with cirrhosis. If it works safely, it may reduce pressure-related complications in people with confirmed liver scarring.
This trial tests whether a medicine called carvedilol can lower high blood pressure in the liver veins of people with cirrhosis. It uses a special ultrasound probe to measure the pressure before and after taking the medicine.
This trial tests if giving albumin, a protein in the blood, can improve outcomes for patients with cirrhosis who have a specific type of bleeding from enlarged veins in the esophagus or stomach.
This trial studies better ways to use endoscopy and other treatments to stop bleeding in the stomach or esophagus caused by high blood pressure in the liver (portal hypertension). It may help if you have been diagnosed with portal hypertension and have varices (enlarged veins) in your esophagus or stomach.
Hear when a new Hypertension, Portal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.